The global bovine blood plasma derivatives market is experiencing significant growth, driven by its expanding applications in pharmaceuticals, food processing, animal nutrition, and biotechnology. The pharmaceutical sector heavily utilizes bovine serum albumin (BSA) for drug formulation and vaccine production, with the biotechnology industry witnessing over 50% adoption rates of BSA in cell culture applications. In animal nutrition, bovine plasma proteins have been proven to improve feed efficiency and immune response, addressing the rising prevalence of livestock diseases globally, where approximately 20% of livestock are affected annually by viral and bacterial infections. Additionally, the food industry leverages plasma derivatives for functional and nutritional benefits, aligning with the increasing demand for protein-rich diets, as evidenced by a 10% annual growth in high-protein food product launches worldwide.
